News

The cost-effectiveness of outbreak responses: Considerations in the COVID-19 era

April 6, 2020 Read Article

The supercar stays in the garage: Why advanced methods for comparing new treatments are used infrequently, and what regulators should do about it

March 17, 2020 Read Article

Crises of Confidence: September 11th vs. Coronavirus

March 17, 2020 Read Article

The societal perspective in cost-effectiveness analysis: ICER has done its part. Now it’s industry’s turn to step up.

February 18, 2020 Read Article

Remembering Rick Hermann

February 4, 2020 Read Article

2020 CEA Registry summer fellowship

January 24, 2020 Read Article

Suicide prevention: A global priority for investment

January 23, 2020 Read Article

Best Books I Read in 2019

December 10, 2019 Read Article

The drug industry may be missing an opportunity to influence ICER

December 4, 2019 Read Article

2019 Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award

November 6, 2019 Read Article